| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/03/2023 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 600 | $215.40 | $129.2k | | 07/03/2023 |
| 07/03/2023 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 400 | $216.03 | $86.4k | | 07/03/2023 |
| 07/03/2023 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 07/03/2023 |
| 04/03/2023 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 04/03/2023 |
| 04/03/2023 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $181.02 | $181k | | 04/03/2023 |
| 01/03/2023 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $197.48 | $197.5k | | 01/03/2023 |
| 01/03/2023 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 01/03/2023 |
| 01/03/2023 | Quanterix Corp | QTRX | Grant | Common Stock | 8.1k | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | Quanterix Corp | QTRX | Grant | Stock Option (Right to Buy) | 12.1k | $12.86 | $155.9k | | 01/03/2023 |
| 10/11/2022 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $205.63 | $205.6k | | 10/11/2022 |
| 10/11/2022 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 10/11/2022 |
| 08/15/2022 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $267.59 | $267.6k | | 08/15/2022 |
| 08/15/2022 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 08/15/2022 |
| 08/15/2022 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 08/15/2022 |
| 06/15/2022 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 5k | $102.96 | $514.8k | | 06/15/2022 |
| 05/27/2022 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 05/27/2022 |
| 05/27/2022 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $110.00 | $110k | | 05/27/2022 |
| 02/15/2022 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 02/15/2022 |
| 02/15/2022 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $110.00 | $110k | | 02/15/2022 |
| 01/03/2022 | Quanterix Corp | QTRX | Grant | Common Stock | 2.7k | $0.00 | $0 | | 01/03/2022 |
| 01/03/2022 | Quanterix Corp | QTRX | Grant | Stock Option (Right to Buy) | 4k | $42.41 | $169.7k | | 01/03/2022 |
| 11/15/2021 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 1000 | $138.24 | $138.2k | | 11/15/2021 |
| 11/15/2021 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 1000 | $84.86 | $84.9k | | 11/15/2021 |
| 06/16/2021 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 8.5k | $128.01 | $1.1M | | 06/16/2021 |
| 06/07/2021 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 4k | $84.86 | $339.4k | | 06/07/2021 |
| 06/07/2021 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 4k | $112.93 | $451.7k | | 06/07/2021 |
| 04/27/2021 | Quanterix Corp | QTRX | Grant | Common Stock | 4.5k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | Quanterix Corp | QTRX | Grant | Stock Option (right to buy) | 15.8k | $77.79 | $1.2M | | 04/27/2021 |
| 08/12/2020 | Karuna Therapeutics, Inc. | KRTX | Grant | Stock Option (Right to Buy) | 25k | $84.86 | $2.1M | | 08/12/2020 |
| 08/13/2018 | PFIZER INC | PFE | Sale | Common Stock | 10.2k | $41.00 | $418.8k | | 08/13/2018 |
| 06/06/2018 | PFIZER INC | PFE | Sale | Common Stock | 15.8k | $36.45 | $574.4k | | 06/06/2018 |
| 06/06/2018 | PFIZER INC | PFE | Sale | Common Stock | 3.2k | $36.46 | $118.2k | | 06/06/2018 |
| 02/28/2018 | PFIZER INC | PFE | Payment of Exercise | Common Stock | 7.4k | $36.31 | $269.4k | | 02/28/2018 |
| 02/28/2018 | PFIZER INC | PFE | Payment of Exercise | Common Stock | 23.4k | $35.70 | $835.3k | | 02/28/2018 |
| 02/28/2018 | PFIZER INC | PFE | Exercise | Stock Appreciation Rights | 38.5k | $27.37 | $1.1M | | 02/28/2018 |
|